These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8350996)

  • 1. The spectrum of levodopa-related fluctuations in Parkinson's disease.
    Riley DE; Lang AE
    Neurology; 1993 Aug; 43(8):1459-64. PubMed ID: 8350996
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic strategies to prevent motor complications in Parkinson's disease.
    Kieburtz K
    J Neurol; 2008 Aug; 255 Suppl 4():42-5. PubMed ID: 18821085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restless legs syndrome and Parkinson's disease: insights into pathophysiology.
    Lang AE
    Clin Neuropharmacol; 1987 Oct; 10(5):476-8. PubMed ID: 3503686
    [No Abstract]   [Full Text] [Related]  

  • 4. Blink reflex in Parkinson's disease with levodopa-induced dyskinesia.
    Iriarte LM; Chacon J; Madrazo J; Chaparro P
    Funct Neurol; 1989; 4(3):257-61. PubMed ID: 2792861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restlessness restricted to the perianal region in a patient with Parkinson's disease.
    Okamura M; Suzuki K; Matsubara T; Hirata K
    Parkinsonism Relat Disord; 2018 Jun; 51():117-118. PubMed ID: 29506822
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk and course of motor complications in a population-based incident Parkinson's disease cohort.
    Bjornestad A; Forsaa EB; Pedersen KF; Tysnes OB; Larsen JP; Alves G
    Parkinsonism Relat Disord; 2016 Jan; 22():48-53. PubMed ID: 26585090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nighttime levodopa infusions to treat motor fluctuations in advanced Parkinson's disease: preliminary observations.
    Sage JI; Mark MH
    Ann Neurol; 1991 Oct; 30(4):616-7. PubMed ID: 1789688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of restless legs syndrome during subthalamic stimulation for Parkinson disease.
    Kedia S; Moro E; Tagliati M; Lang AE; Kumar R
    Neurology; 2004 Dec; 63(12):2410-2. PubMed ID: 15623715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Motor complications in patients with Parkinson disease treated with levodopa].
    Luquin MR; Obeso JA; Martínez-Lage JM
    Neurologia; 1989; 4(1):4-11. PubMed ID: 2631806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating motor fluctuations with controlled-release levodopa preparations.
    Koller WC; Pahwa R
    Neurology; 1994 Jul; 44(7 Suppl 6):S23-8. PubMed ID: 8047257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological strategies for controlling motor fluctuations in Parkinson's disease.
    Ruggieri S; Carta A; Stocchi F; Antonini A; Bellantuono P; Monge A
    Funct Neurol; 1988; 3(4):471-9. PubMed ID: 3072281
    [No Abstract]   [Full Text] [Related]  

  • 12. Force overflow and levodopa-induced dyskinesias in Parkinson's disease.
    Wenzelburger R; Zhang BR; Pohle S; Klebe S; Lorenz D; Herzog J; Wilms H; Deuschl G; Krack P
    Brain; 2002 Apr; 125(Pt 4):871-9. PubMed ID: 11912119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impulse control disorders in advanced Parkinson's disease with dyskinesia: The ALTHEA study.
    Biundo R; Weis L; Abbruzzese G; Calandra-Buonaura G; Cortelli P; Jori MC; Lopiano L; Marconi R; Matinella A; Morgante F; Nicoletti A; Tamburini T; Tinazzi M; Zappia M; Vorovenci RJ; Antonini A
    Mov Disord; 2017 Nov; 32(11):1557-1565. PubMed ID: 28960475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amantadine extended release for levodopa-induced dyskinesia in Parkinson's disease (EASED Study).
    Pahwa R; Tanner CM; Hauser RA; Sethi K; Isaacson S; Truong D; Struck L; Ruby AE; McClure NL; Went GT; Stempien MJ
    Mov Disord; 2015 May; 30(6):788-95. PubMed ID: 25650051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous dopaminergic stimulation for Parkinson's disease: facts and fancy.
    Obeso JA; Grandas F; Vaamonde J; Luquin MR; Martinez-Lage JM
    Funct Neurol; 1988; 3(4):413-27. PubMed ID: 3072277
    [No Abstract]   [Full Text] [Related]  

  • 16. [Dyskinesia-hyperpyrexia syndrome in a patient with Parkinson's disease: a case report].
    Taguchi S; Niwa J; Ibi T; Doyu M
    Rinsho Shinkeigaku; 2015; 55(3):182-4. PubMed ID: 25786757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motor fluctuations in Parkinson's disease: pathogenetic and therapeutic studies.
    Mouradian MM; Juncos JL; Fabbrini G; Chase TN
    Ann Neurol; 1987 Oct; 22(4):475-9. PubMed ID: 3435068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pain fluctuations in Parkinson's disease].
    Yakovleva LA; Zalyalova ZA; Altunbaev RA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(9):41-44. PubMed ID: 26525814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of dyskinesias in advanced Parkinson's disease. I. Continuous intravenous levodopa shifts dose response for production of dyskinesias but not for relief of parkinsonism in patients with advanced Parkinson's disease.
    Schuh LA; Bennett JP
    Neurology; 1993 Aug; 43(8):1545-50. PubMed ID: 8351009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long-acting dopamine receptor agonist cabergoline in early Parkinson's disease: final results of a 5-year, double-blind, levodopa-controlled study.
    Bracco F; Battaglia A; Chouza C; Dupont E; Gershanik O; Marti Masso JF; Montastruc JL;
    CNS Drugs; 2004; 18(11):733-46. PubMed ID: 15330687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.